An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)

Lundbeck

Status and phase: Completed; Phase 3

Conditions: Insomnia

Treatments: Drug: gaboxadol; Drug: Comparator: placebo (unspecified)

Study type: Interventional

Funder types: Industry

Identifiers

NCT00103818

MK0928-014

2005_002

0928-014

Details and patient eligibility

About

The purpose of this study is to evaluate the safety and effectiveness of MK0928 for insomnia (a sleep disorder).

Enrollment: 900 patients

Sex: All

Ages: 18 to 64 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult outpatients who are between the ages of 18 and 64

Exclusion criteria

• Adults who do not have a diagnosis of insomnia (a sleep disorder)

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind